Amicus Therapeutics, Inc. (DELISTED) (FOLD:DL)
14.49
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
Amicus Therapeutics EPS Diluted (Quarterly) : 0.0054 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.0054 |
| September 30, 2025 | 0.0558 |
| June 30, 2025 | -0.0792 |
| March 31, 2025 | -0.0705 |
| December 31, 2024 | 0.0493 |
| September 30, 2024 | -0.0221 |
| June 30, 2024 | -0.0517 |
| March 31, 2024 | -0.1598 |
| December 31, 2023 | -0.1153 |
| September 30, 2023 | -0.073 |
| June 30, 2023 | -0.1476 |
| March 31, 2023 | -0.1817 |
| December 31, 2022 | -0.1987 |
| September 30, 2022 | -0.1151 |
| June 30, 2022 | -0.2129 |
| March 31, 2022 | -0.2956 |
| December 31, 2021 | -0.2986 |
| September 30, 2021 | -0.188 |
| June 30, 2021 | -0.1923 |
| March 31, 2021 | -0.2484 |
| December 31, 2020 | -0.2725 |
| September 30, 2020 | -0.247 |
| June 30, 2020 | -0.2035 |
| March 31, 2020 | -0.3461 |
| December 31, 2019 | -0.3513 |
| Date | Value |
|---|---|
| September 30, 2019 | -0.2427 |
| June 30, 2019 | -0.3551 |
| March 31, 2019 | -0.5634 |
| December 31, 2018 | -0.4123 |
| September 30, 2018 | -0.8414 |
| June 30, 2018 | -0.3278 |
| March 31, 2018 | -0.2836 |
| December 31, 2017 | -0.4144 |
| September 30, 2017 | -0.69 |
| June 30, 2017 | -0.3366 |
| March 31, 2017 | -0.3852 |
| December 31, 2016 | -0.411 |
| September 30, 2016 | -0.33 |
| June 30, 2016 | -0.40 |
| March 31, 2016 | -0.35 |
| December 31, 2015 | -0.34 |
| September 30, 2015 | -0.32 |
| June 30, 2015 | -0.27 |
| March 31, 2015 | -0.25 |
| December 31, 2014 | -0.24 |
| September 30, 2014 | -0.22 |
| June 30, 2014 | -0.22 |
| March 31, 2014 | -0.25 |
| December 31, 2013 | -0.22 |
| September 30, 2013 | -0.29 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 0.2302 |
| Insmed, Inc. | -0.0609 |
| Ligand Pharmaceuticals, Inc. | 2.221 |
| PTC Therapeutics, Inc. | 0.9178 |
| Establishment Labs Holdings, Inc. | -0.39 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.69M |
| Revenue (Quarterly) | 185.21M |
| Total Expenses (Quarterly) | 183.52M |
| Enterprise Value | 4.699B |
| Gross Profit Margin (Quarterly) | 84.64% |
| Profit Margin (Quarterly) | 0.91% |
| Earnings Yield | -0.61% |
| Operating Earnings Yield | 0.77% |
| Normalized Earnings Yield | -0.5845 |